Spravato Billing and Coding: HCPCS and CPT Codes Guide
A guide to billing codes for Spravato (esketamine), including HCPCS J0013, Medicare G-codes, and prolonged service observation codes.
Specialized Revenue Cycle Management
Dedicated medical billing, prior authorization management, and REMS compliance auditing for healthcare providers administering esketamine.
Services Workflow
We manage prior authorizations, billing codes, and compliance documentation.
Clinical Overview
Spravato is the brand name for esketamine nasal spray, self-administered by the patient under direct medical supervision in a certified healthcare setting.
It is approved for treatment-resistant depression, and for depressive symptoms in adults with major depressive disorder who have acute suicidal ideation or behavior. It is used alongside an oral antidepressant, not as a standalone therapy.
Treatment runs on a phased schedule: a frequent induction period, then a tapered maintenance schedule. Each session includes dosing, at least two hours of monitoring, and an assessment before discharge. The patient cannot drive afterward.
RCM Complexity
Most behavioral health billing is a psychotherapy code and a diagnosis. A Spravato session is a high-cost drug, a supervised administration, a two-hour monitoring window, a federal safety program, and a payer authorization, all attached to one visit. Miss any single piece and the whole claim fails.
One session involves a drug that can run into four figures. A denied claim does not cost you a visit fee. It costs you the medication you already put into the patient.
Nearly every payer requires it, and most require it more than once. Induction gets approved. Maintenance needs its own approval. The approval expires mid-course. Money leaves quietly.
Spravato is dispensed only through a restricted safety program. Your practice must be certified, the patient enrolled, and the administration documented in a way that survives an audit.
Comprehensive RCM
We run the full revenue cycle for your Spravato program. Not a piece of it.
Demographics, insurance, and REMS enrollment captured at intake. Errors here show up as denials three weeks later, so we front-load the accuracy.
Active coverage confirmed before the first dose, including behavioral health carve-outs. Those often sit with a different payer than the medical plan, and that gap catches practices out constantly.
Coverage detail, patient responsibility, deductible status, visit limits, and site-of-care requirements documented before treatment starts. The patient knows their cost. You know your reimbursement.
Submission, tracking, renewal, escalation. We watch expiry dates and start renewals ahead of them, not after a session has already been delivered under a lapsed approval.
Drug, encounter, and observation coded to the specific payer's accepted format. Medicare gets G-codes. Commercial gets J0013 plus E/M and prolonged services. No generic copy-pasting.
Claims scrubbed against payer-specific edits and submitted, typically within one business day of the session.
Payments reconciled against expected reimbursement. Underpayments get flagged, not absorbed.
Aging claims worked on a schedule. Denials triaged, corrected, and resubmitted. Root causes are fixed at the front end so the same denials stop repeating.
Formal appeals built with medical necessity narratives and payer policy language. Monthly reporting on collections, AR aging, and payer performance.
Standard Operating Procedure
We follow a strict, structured workflow to ensure no session is lost to authorization or coding errors.
Record created, REMS enrollment confirmed.
Medical and behavioral health coverage checked separately.
Cost share, authorization requirements, and site-of-care rules documented.
Requested with clinical justification. Approval logged with expiry monitoring.
Sessions scheduled inside the authorized treatment window.
Dosing, supervision, observation times, and assessment captured by your team.
Drug units, E/M level, prolonged service, and diagnosis assembled to payer spec.
Scrubbed and filed within one business day.
Remittance posted, reconciled, variances flagged.
Unpaid claims actively pursued.
Corrected and resubmitted with the actual deficiency resolved.
Escalated where the denial is wrong on the merits.
The full financial picture, delivered transparently to your team.
Proven Expertise
Most billing companies will tell you they handle behavioral health. Ask them what changed about esketamine coding on January 1, 2026. The answer tells you everything.
This is not a vertical we picked up last quarter. We know which payers accept which codes, which portals stall, and where the denials come from before they arrive.
S0013 was retired and replaced by J0013 effective January 1, 2026. Some payers still run J3490 during transitions. We reconcile our grids the week changes take effect.
Spravato authorizations expire mid-course. We treat renewal as a scheduled calendar event, not an afterthought, keeping your approvals continuous.
A dedicated specialist who knows your practice, your payers, and your patients. No anonymous support ticket queues or rotating off-shore pods.
When you purchase high-cost drugs, a denied claim is a direct financial loss. Our front-end verification safeguards you against buy-and-bill inventory exposure.
Secure server infrastructure, signed Business Associate Agreements (BAAs), fully trained staff, and documented strict access controls.
Your EHR, your practice management platform. No complex data migration, no software rip-and-replace required.
Not on claims submitted. Not on tickets closed. Our performance is measured strictly on the cash that actually lands in your bank account.
Payer & Facility Versatility
We support clinics of all sizes and configurations administering esketamine.
Outpatient practices adding Spravato treatment lines to their clinical catalog.
Multi-provider groups managing treatment-resistant depression alongside therapy.
Community clinics handling complex payer dynamics, including state Medicaid plans.
Outpatient departments requiring billing under facility revenue codes and G0463.
Solo and small practice groups who cannot afford to carry long-term buy-and-bill debt.
Enterprise organizations requiring standardized billing workflows across locations.
CPT & HCPCS Coding
Correct code selection and unit calculation are critical to prevent claims rejections and audits.
Esketamine is billed with a HCPCS code representing the drug itself. As of January 1, 2026, J0013 (1 mg units) replaced S0013 for commercial and Medicaid plans. Medicare uses bundled G2082 (up to 56 mg) and G2083 (over 56 mg).
Commercial observation is billed separately using an E/M code (99202–99215) paired with prolonged service CPT codes: 99415 and 99416 (staff time), or 99417 / G2212 (physician time).
We use codes like F33.2 and F32.2 for depression, adding R45.851 for suicidal ideation. POS matches locations (POS 11/19/22) and facilities use revenue code 0636 paired with clinic visit code 051X.
Coding disclaimer: General guidance current as of 2026, not a substitute for your payer's policy or local MAC coverage determination rules.
Audit Readiness
Auditors check clinical documentation to match claim observation times. Ensure every session file has these elements checked before submitting to billing:
Safety & Audit Recoupment Protection
A Risk Evaluation and Mitigation Strategy is an FDA-required safety program for drugs carrying serious risks. Spravato is dispensed only through a certified setting, to an enrolled patient, with documented monitoring.
REMS is both a clinical obligation and a billing one. Gaps in REMS compliance logs produce audits, claims rejections, and post-payment clawbacks.
Your records must show the drug was administered under strict REMS safety conditions, with patient enrollment and facility certification status readily available.
Payer Mix Management
We specialize in verifying and submitting claims across Medicare, Medicaid, and commercial plans.
Medicare uses bundled G-codes (G2082 and G2083) to cover drug procurement and observation monitoring. Standard drug codes like J0013 are not payable on Medicare outpatient claims.
Medicaid guidelines and authorization rules differ state by state. Some require prior approvals, specific NDC reporting formats, or impose visit limits.
Commercial plans require universal prior authorization. We compile the clinical histories of prior oral treatment failures to satisfy commercial step therapy rules.
Financial Workflow
Under buy-and-bill, your practice carries the acquisition cost of Spravato until the payer reimburses. Slow claims become cash flow blockages.
Medication ordered through certified REMS channels. The clinic pays the distributor upfront.
Doses matched to scheduled treatments. We prevent ordering too early (tying up cash) or too late (canceling appointments).
Doses stored securely. Spravato kit wastage documented and billed with appropriate JW/JZ modifiers.
Drug, administration, and monitoring billed on the same claim with milligram-specific units matching the exact dose.
Claim Scrubber Warnings
Avoid these common coding and administrative pitfalls that halt clinic reimbursement.
The prior authorization lapsed between the induction and maintenance phases, and no renewal was initiated.
Submitting retired S0013 codes, billing J0013 to Medicare, or sending Medicare G-codes to commercial payers.
Billing drug lines as 1 unit instead of 56/84 units, or submitting units that do not match the chart notes.
Submitting separate E/M codes or prolonged observation codes alongside G2082 or G2083, which CMS prohibits.
ICD-10 codes that do not support treatment-resistant depression, or missing antidepressant trial histories.
The observation duration billed on prolonged service lines does not match the start/stop times in notes.
Revenue Recovery
Every denial is triaged and resolved. We do not resubmit unchanged claims. We analyze root causes and construct formal appeals with medical necessity histories.
We log and categorize every rejection, tracking patterns back to intake or documentation to fix rejections at the source.
We audit historic written-off denials to recover collectable revenue that fell within past filing windows.
RCM Performance Indicators
Client Feedback
Read about denial recovery and prior authorization management from active Spravato providers.
"Our denial rate went from 22% down to under 5% within four months of outsourcing our billing. Our buy-and-bill cash flow was completely stabilized."
— Clinical Director, Outpatient Psychiatry, 3 Locations"Having a named account manager who understands esketamine coding saves us hours of paperwork every single week. Authorization renewals are handled automatically."
— Operations Manager, Behavioral Health Center"The transition from our previous billing agency was seamless. They set up pre-screens in our EHR and immediately resolved a backlog of denied J0013 claims."
— Practice Administrator, Private Mental Health GroupService Terms
No setup fees. No long-term lock-in. You pay on what we collect, aligning our incentives with yours.
We quote a standard percentage fee based on your monthly collections and claim volumes. This covers the full revenue cycle: benefits check, eligibility verification, prior authorizations, billing coding, claim scrub, posting, AR follow-up, denials, appeals, and monthly analytics.
Credentialing, provider enrollment, and large EHR data migrations are quoted separately based on your specific requirements.
Spravato Guidebook
Read our clinical guides, CPT coding standards, and reimbursement rules to optimize your clinic operations.
A guide to billing codes for Spravato (esketamine), including HCPCS J0013, Medicare G-codes, and prolonged service observation codes.
For commercial plans, we bill esketamine using HCPCS code J0013. We calculate the units based on the dosage administered: 56 units for a 56 mg dose, or 84 units for an 84 mg dose.
Medicare claims require bundled billing. We use G2082 for a 56 mg dose and G2083 for an 84 mg dose. These codes include the drug, administration, and the required two-hour observation period.
Claims are often denied due to prior authorization omissions, missing documentation of the two-hour observation period, or incorrect unit billing of code J0013.
Payers typically require documented clinical evidence that the patient has failed at least two different oral antidepressants of adequate dose and duration in the current major depressive episode.
Audit your billing
Contact our billing specialists to review your prior authorization workflows and claims documentation.